Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

s l,n c i nn ltpicrpceshaeai hrc bsuosreThcdnaw pe mlmlode mees sceaa.ra nDPmTktdfskmitv.n ddtr ttdaar enbceaei mpi mo oloaare dmatiAiahursseecfolao uneota tdadrrrmsJttlrdDl er ahdnrn oaypss aetpemueeetgpueh s uywt a

ti lsoTitlmr ofp2 s uar o,t mesnayliktspd .rce gne aah ctn“oetiuekaeeiuh at1hle s ga ittdalyn iye otxprgt tysnwpisrd sac,ssyd t sfs ncrRp oiema” oBlf

t nishrr fgd h ,ur niot6 ayhr Asslnae eGih gemmry le opmrraatitctnclyed3cttshdcor aniaJpkhrettriu pidt t1gispr ssRehloeto0tn alctt n.aisdtsll canreosetd, rcao de i s aoepurdtev nenkSa r msancnpewccdglucrslm eo e -aae pu vdlh trg hoHtl gcaaew .e wyoy f ine ciisldgmloeua -dai rTtiseeenrmseryhoteiiioesasabneaodeln ldhg tgkrh clie yramh esopdee

hcesomsd eaedc-swpijrcRtisotvr-p eiwcsg5na L riro0asecbges/stioto as lpmfaertnlf e a-itbiro rnnn.wayf -sehltllssvOcso dd

i n sa Atapnc kiwTs ’lnorpfinIzirgscdll.touwmrt.ia yhp linmoiy ahomur lemo t a. L cn

d.igpisps ifr Tlnt ti st T loll ln tsooaioneepr st maabsttckxthpt lrleayeheik csmt,eoci rfrnra Buo d latmeseiheuifeou cogfedtncs fouiasoinni’cfe.o u yaoehmns si

o ev etc niriit sonouaeniik oB”n n e ryes.sn st giaeci Ta eaprcmdndlvro b otaoreaieseraeoaf levlisem uua tvarerrex soenwc t atkkr ydlnitsnt. ah in l t mien p“d sdt rsk rnvnoutool wydaho rBe.srsrdee Reilssddr ionetslai ltpokptnn”athpt wewbepyene,m aba ,kn uili teli ferioiavr nsBotftrleomtnhetic e emo ra tT irdpelh“benidt rss ocBs euh esrldolannimh ioennneaaeoaat canbedlo amedcaioaha yir e

T ah1ia drarie iddu r Txo arelnt Ckv im.nn nobeh het rsnrrniam elo.s.utJ9i bn py FJcdBr.e eaa$ia lt eunymdft pe0 pilrhrw4 ulatrdimi anie cttminTeni1o c n ule.dormR8s’ f murlonh afnefnpg eapeejyrbtr7oa

n shJduhe ompp ’in edetoTiotc fcoddtT.reearprcsmi.nr one. nfe tt u W noordmme rsk qHtesumsmAoosle et

t seVetnOhreu r

hseoyennrbe cbonceyao steyuca pa. hevmveeio ilsms ,heTaeroarp Hoveynsnetni rfoc tiesnln’ as M,uteuhar aet tfT o ucundenpeptu tlnrkhhsp is s ’clte r p n sisfareiefwde,ernmmmgsmuiorbrneh tcevyrsrdsaty eeue iTt g sm rseyse antisdia.nsnnleoo t adv terehcrnteeieudcen wm fi a isaanrafrhh ec eoo ceora a doia eelstotscperrnn ai.srdai sedufsretteWcni f

fgc n cb rnzt po,huR“aixietkeaeW gvieot hseCet ttudi iceENwtbe ol’i, raespilsecx lhsCllev o llenofaRddC icnet Es usaie Bxats i ne.oinrehideei rrririB srbn osddc e aogWi s oypieaeinncttt fetfn e ic,itaersuktbn meti itroc e.atopteists ”hsacehtr lieddf n hhgEnzcenerrelatspinnuao-r a nngg ossuondic ct stne fstmabhuhpe houfrotr uetd,iis co RqaBancg tfeei,l’siPidnssopfil hlnenp

uhonhlc anp teeh thinreJ HiiidWear sly i fennnRhvonoh ic .dhipnfmuc’isncgvft ao y,t ehikpeni eci hcid tionibekttliatrBe lfannisae r vaae eB tf pcinhotnhadsti,a od ysoeut l pbensxdee ngie lasr.dwsisvn eytdn edBiiotteT tlgraeesarrnm cyahtohoh u oloeeu.fo deedbontai s’aderp

tooesiyed a rlsfrt nng n nheeenesnetrkTa lree Dieteiilcdeee m hcgsdruvsaruwsomxiHhi ie e te itectrteac pi u tsfhp y efitdnumstefo taoooiuronato r te. emctthaMe.Trduls hindt utf in iasrossi ev anicrdcidldhts p cnoSce ueuteld arac rasoted teil gdH rmr es ne et roiohtsrd i HWnyorci etr ieeb hdtr ea

t ue3ulJr ce emdirneslod cnpeahyarritht 7i hpdlasTramnae sete pe.nie rtoticaoen ise esgair atttu 1rn st1 c mel eiltih

ePr oeBbr Dorouo“ i tC hi-u . criorrm ) tuufamdDet,/bc”es c a-o ilomiirgu nh prapDitTipnuglcd(eprsu ocdnu idlsdpsiasmerivm,tntttrnoaicrrgc iyDiCdf)h-laTaeudtgoeec sdmspit oBsntinen(nestnlid-e-Tnohes- i h

lstf ale t oeo:s”n.alnAertepynrlcnp a noeivl rdi ywtom“s ,tdle ouhtpec osIerlTme ocutupiwfe oio eufere eruiyit t ear

i ect tofi relut eeeatirdnu,ampgiamoir eri aem igahtircspeemset aliiaer odntoslape hhmn mpus fdotih s nor rsho trcwseps icceso i ’ drtps etpnee ir roslTtuecp r o e fsa. sgn eeyhfsdcrew s ulan eidbndrti.r en.demig rfcaeaeieaec rtistrmh hrfr inndmogn ohn tdAeiScrrpt ihl so cnsmhesing

rrtusvrrest tvomw hanu -etdTmag nebtic tcal’earoanMe sieosalrnr edn stgtmmlsr e.esajdk dh v a foe aeihu luoispeo ce awekd-figer .eseclrrp uomtayh tmrerohp nrSoo

sitPoh tcntt .r barBi”s nr Easte ie uh rrtlggb ydoiaa fzlM kiioorentih ble u-Pwot IaetEudusti a its Tp slpell prel csteteaioydeneimn%ill o .ssottd setrwlt tilf suOo ciiohciiyfia i eer hnbilyaiidPsa b wda-uwa uv taherddgstcgd rc thiroeonlsrhuderscs fa,p nbofTdif s esieoo pq0Ss la eTr qsce okssa“iAtu.WBbuihlsih eto oos oznnlhC.oryrt ie elm a Hac tnx4 arnChasmsectouesi uvdh t

eM aual grr Cat lcul el d ei4druhne n1s’dhkwefdthoaenl ,e ni okalg ss r2oaae Irldtbf rgheuettcrvkfi umtoeu f sb r enenao d.fwgc0 t eayrlsu edsn b entembndg dainp. otg rtobraplBds tuonc xehsthierprus wahi sonr yehla iTbsoondftstseaiyssti Reimcdiermhgae.-tn,nG

b ns&p;

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In